C6ORF35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.66373598126302E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.19090000083588E-08 |
Normal-vs-Stage2 |
7.57600000511616E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
4.574400E-02 |
Stage1-vs-Stage3 |
4.53400000000048E-06 |
Stage1-vs-Stage4 |
6.34569999991008E-07 |
Stage2-vs-Stage3 |
4.622800E-01 |
Stage2-vs-Stage4 |
2.112600E-01 |
Stage3-vs-Stage4 |
3.935400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
3.000900E-04 |
Normal-vs-Asian |
1.308500E-02 |
Caucasian-vs-AfricanAmerican |
8.699900E-03 |
Caucasian-vs-Asian |
6.933000E-01 |
AfricanAmerican-vs-Asian |
5.897600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.55111512312578E-16 |
Normal-vs-Female |
3.23020055148504E-10 |
Male-vs-Female |
5.583900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.896800E-03 |
Normal-vs-Age(41-60Yrs) |
1.61779478702329E-11 |
Normal-vs-Age(61-80Yrs) |
1.62658775337832E-12 |
Normal-vs-Age(81-100Yrs) |
8.40699998505556E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.866200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.978000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.496500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.256300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.172600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.389600E-01 |
Normal-vs-Grade 2 |
7.98089999642926E-08 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
4.192200E-02 |
Grade 1-vs-Grade 3 |
3.87290000000151E-05 |
Grade 1-vs-Grade 4 |
4.16280000026248E-07 |
Grade 2-vs-Grade 3 |
3.85489999998878E-06 |
Grade 2-vs-Grade 4 |
1.52750000426138E-08 |
Grade 3-vs-Grade 4 |
3.420300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.49749999464899E-08 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
9.3335999995503E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.76214598468505E-12 |
Normal-vs-N1 |
3.45170003690498E-10 |
N0-vs-N1 |
2.980400E-03 |
|
|